← Leaderboards
James K Turkson
University Of Central Florida
$9,035,575
Attributed
$9,035,575
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $832.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,035,575 · 7
By mechanism
R01$8,923,658 · 5
P30$106,917 · 1
R13$5,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularGrowthBaseEventLeadCellsIn VitroIn VivoAnalogTumorMalignant NeoplasmsSignal TransductionNeoplastic CellXenograft ProcedureStat3 ProteinBiologyPropertyProteinsBiochemicalSmall MoleculeInhibitor/AntagonistMalignant Breast NeoplasmMammary NeoplasmsBiological
Grant awards (29)
Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3$686,846
R01 · FY2025 · CA · contact PI
Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3$703,595
R01 · FY2024 · CA · contact PI
Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3$128,902
R01 · FY2024 · CA · contact PI
11th Annual Meeting of International Cytokine & Interferon Society$5,000
R13 · FY2023 · AI · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides$549,875
R01 · FY2021 · CA · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides$599,483
R01 · FY2020 · CA · contact PI
Cancer Biology Program$37,110
P30 · FY2020 · CA · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides$357,057
R01 · FY2019 · CA · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides$262,845
R01 · FY2019 · CA · contact PI
Cancer Biology Program$36,863
P30 · FY2019 · CA · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides$502,653
R01 · FY2018 · CA · contact PI
Cancer Biology Program$32,944
P30 · FY2018 · CA · contact PI
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides$671,829
R01 · FY2017 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$480,634
R01 · FY2016 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$480,634
R01 · FY2015 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$467,825
R01 · FY2014 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$78,134
R01 · FY2014 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$423,885
R01 · FY2013 · CA · contact PI
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy$489,360
R01 · FY2012 · CA · contact PI
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer$223,913
R01 · FY2011 · CA · contact PI
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer$211,529
R01 · FY2010 · CA · contact PI
STATs as a Novel Approach to Cancer Therapy$235,295
R01 · FY2009 · CA · contact PI
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer$182,007
R01 · FY2009 · CA · contact PI
STATs as a Novel Approach to Cancer Therapy$235,295
R01 · FY2008 · CA · contact PI
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer$188,029
R01 · FY2008 · CA · contact PI
STATs as a Novel Approach to Cancer Therapy$235,295
R01 · FY2007 · CA · contact PI
STATs as a Novel Approach to Cancer Therapy$242,814
R01 · FY2006 · CA · contact PI
STATs as a Novel Approach to Cancer Therapy$173,399
R01 · FY2005 · CA
STATs as a Novel Approach to Cancer Therapy$112,525
R01 · FY2005 · CA